Literature DB >> 32261838

In situ synthesis, characterization and in vitro studies of ciprofloxacin loaded hydroxyapatite nanoparticles for the treatment of osteomyelitis.

G Suresh Kumar1, R Govindan, E K Girija.   

Abstract

Bioactive materials in combination with antibiotics are widely developed for the treatment of osteomyelitis which play a dual role: as bone substitutes at the affected site and as local drug delivery systems for antibiotic delivery. In the present study, a series of ciprofloxacin loaded hydroxyapatite (HA) nanoparticles with sustained and prolonged release behavior has been synthesized by an in situ precipitation method. The amount of ciprofloxacin loaded on HA nanoparticles can be easily adjusted by changing the initial concentration during the synthesis. It was observed that as the loaded concentration of ciprofloxacin increases the release is sustained and prolonged. The in situ loading of ciprofloxacin onto HA nanoparticles does not significantly affect the bioactivity and cytocompatibility of HA whereas it provides antibacterial activity to HA against S. aureus and E. coli that causes osteomyelitis. Consequently synthesized ciprofloxacin loaded HA nanoparticles can be potential candidates for the treatment of osteomyelitis.

Entities:  

Year:  2014        PMID: 32261838     DOI: 10.1039/c4tb00339j

Source DB:  PubMed          Journal:  J Mater Chem B        ISSN: 2050-750X            Impact factor:   6.331


  2 in total

Review 1.  Different Nanotechnology Approaches for Ciprofloxacin Delivery Against Multidrug-Resistant Microbes.

Authors:  Ashagrachew Tewabe Yayehrad; Gebremariam Birhanu Wondie; Tesfa Marew
Journal:  Infect Drug Resist       Date:  2022-02-05       Impact factor: 4.003

2.  Development and Optimization of Ciprofloxacin HCl-Loaded Chitosan Nanoparticles Using Box-Behnken Experimental Design.

Authors:  Noha M Soliman; Faiyaz Shakeel; Nazrul Haq; Fars K Alanazi; Sultan Alshehri; Mohsen Bayomi; Ahmed S M Alenazi; Ibrahim A Alsarra
Journal:  Molecules       Date:  2022-07-13       Impact factor: 4.927

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.